Bilateral Ultrasound-Guided Erector Spinae Plane Block for Perioperative Analgesia in Breast Reduction Surgery: A Prospective Randomized and Controlled Trial.

Autor: Tunay DL; Department of Anesthesiology and Intensive Care, Faculty of Medicine, Cukurova University, Balcali Hospital, Adana, Turkey. dlafli@yahoo.com., Ilginel MT; Department of Anesthesiology and Intensive Care, Faculty of Medicine, Cukurova University, Balcali Hospital, Adana, Turkey., Karacaer F; Department of Anesthesiology and Intensive Care, Faculty of Medicine, Cukurova University, Balcali Hospital, Adana, Turkey., Biricik E; Department of Anesthesiology and Intensive Care, Faculty of Medicine, Cukurova University, Balcali Hospital, Adana, Turkey., Tabakan I; Department of Plastic Reconstructive and Aesthetic Surgery, Faculty of Medicine, Cukurova University, Balcali Hospital, Adana, Turkey., Ozmete O; Department of Anesthesiology and Intensive Care, Baskent University School of Medicine, Adana, Turkey.
Jazyk: angličtina
Zdroj: Aesthetic plastic surgery [Aesthetic Plast Surg] 2023 Aug; Vol. 47 (4), pp. 1279-1288. Date of Electronic Publication: 2023 Mar 16.
DOI: 10.1007/s00266-023-03315-0
Abstrakt: Background: Ultrasound-guided erector spinae plane block (ESPB) is an interfascial plane block used for analgesia of the chest and abdominal wall. This study aimed to evaluate the perioperative analgesic efficacy of bilateral single-shot ESPB at T5 vertebral level in breast reduction surgery.
Materials and Methods: Sixty adult female patients scheduled for breast reduction surgery were included and randomly allocated to two groups to receive either preoperative ESPB with a local anesthetic mixture of 10 mL 0.5% bupivacaine, 5 mL 2% lidocaine, and 5 mL saline, or sham block. Patients in both groups received intraoperative remifentanil infusion and, postoperatively, morphine via the patient-controlled analgesia (PCA) device. The primary outcome was 24-h total morphine consumption, and secondary outcomes included intraoperative opioid consumption, postoperative pain intensity, time to first PCA request, supplement analgesic requirements, functional recovery, patient satisfaction, length of hospital stay, and side effects and complications.
Results: The 24-h total morphine consumption was significantly lower in the ESPB group vs. the sham group (mean ± SD, 6.7 ± 3.9, and 13.9 ± 5.7 mg, respectively, p < 0.001). Compared with sham block, ESPB reduced pain scores, intraoperative opioid consumption, supplement analgesic requirements, delayed time to first PCA request, and improved functional recovery and patient satisfaction.
Conclusion: In breast reduction surgery, preoperative single-shot ESPB reduces perioperative opioid consumption and provides adequate pain relief within 24 h postoperatively compared to systemic analgesics alone.
Trial Registration Number: NCT03621345 LEVEL OF EVIDENCE II: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .
(© 2023. Springer Science+Business Media, LLC, part of Springer Nature and International Society of Aesthetic Plastic Surgery.)
Databáze: MEDLINE
Externí odkaz: